SRTD Biotech

SRTD Biotech is a German biotechnology company developing next-generation precision mRNA therapeutics. Its proprietary technology enables cell-specific mRNA expression by leveraging intracellular disease markers to selectively activate therapeutic payloads within target cells, while minimizing exposure in healthy tissue. The company is advancing a pipeline of novel targeted RNA therapies across oncology, autoimmune diseases and fibrosis.

Team

Venture Capital

Status

Current

Geography

Europe

Financing Round

Seed

Segment

Diagnostic & Therapeutic Platforms

Entry Date

2026

Key Figures

Current

Status

2019

Creation Date

2026

Investment Date

Mérieux Innovation 2

Fund Name

Key Contacts

Related companies